Can you believe that Moderna (NASDAQ: MRNA) was once worth more than $195 billion in 2021? Back then, the business looked on track to be the next big healthcare company.

Then, demand for its COVID-19 vaccine started to diminish. As hospitals resumed normal operations and anti-vaccine sentiment grew, there wasn't nearly as much demand for COVID-19 shots anymore. While Moderna still generates revenue from its vaccine, it's just a fraction of what it was in 2021.

Image source: Getty Images.

Continue reading

Source Fool.com